Page 77 - Annual Report
P. 77

HONG KONG ACADEMY OF MEDICINE
            香 港 醫 學 專 科 學 院
            香港醫學專科學院
            CONSOLIDATED STATEMENT OF CASH FLOWS
            FOR THE YEAR ENDED 31 DECEMBER 2023



                                                                    Note             2023            2022
                                                                                      HK$             HK$
            Operating activities
              Surplus/(deficit) for the year                                    10,662,320      (9,237,977)
              Adjustments for:
                 Depreciation                                                    5,579,105       9,332,261
                 Interest income                                                (2,631,995)       (791,368)
                 Dividend income from other financial assets                      (432,577)       (348,818)

            Operating cash flows before changes in working
              capital                                                           13,176,853      (1,045,902)

                Increase in inventories                                           (207,957)        (43,758)
                Decrease/(increase) in prepayments, deposits and
                   other receivables                                             1,120,919      (3,880,742)
                Decrease in deferred income                                       (485,902)     (1,649,486)
                Increase in accruals and other payables                          3,475,313       1,585,070

            Net cash generated from/(used in) operating activities              17,079,226      (5,034,818)

            Investing activities
              Purchase of property, plant and equipment                           (914,253)     (4,956,191)
              (Placement)/withdrawal of time deposits                          (35,028,630)     30,759,475
              Interest received                                                  2,631,995         791,368
              Dividend received from other financial assets                       432,577          348,818

            Net cash (used in)/generated from investing activities             (32,878,311)     26,943,470

            Net (decrease)/increase in cash and cash equivalents               (15,799,085)     21,908,652

            Cash and cash equivalents at 1 January                              44,833,352      22,924,700

            Cash and cash equivalents at 31 December                 13         29,034,267      44,833,352















            The accompanying notes form an integral part of these consolidated financial statements.






 7                                                         8   8


                                                                                                                 75
                                                                                    香港醫學專科學院 2024 年度報告
   72   73   74   75   76   77   78   79   80   81   82